2009 Annual Monday

Orlando, FL - ASCO 2009 Annual Meeting: Eric Van Cutsem, MD, PhD discusses Abstract LBA4509 - Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC). during the Oral Presentation at the American Society for Clinical Oncology Annual Meeting here today, Monday June 1, 2009. Over 25,000 physicians, researchers and healthcare professionals from over 80 countries are attending the meeting which is being held at the Orange County Convention center and features the latest cancer research in the areas of basic and clinical science. Date: Monday June 1, 2009 Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.